Inna Sekirov
Overview
Explore the profile of Inna Sekirov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
3918
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marquez A, Tanunliong G, Kabir M, Alam M, Hossain B, Rashid H, et al.
Viruses
. 2025 Feb;
17(2).
PMID: 40006916
There is a limited understanding of the immunological differences between children and adults that protect children from developing severe coronavirus disease 2019 (COVID-19) following SARS-CoV-2 infection. Previous infection with endemic...
2.
Gharamaleki O, Colijn C, Sekirov I, Johnston J, Sobkowiak B
Sci Rep
. 2024 Nov;
14(1):27652.
PMID: 39532933
Identifying individuals with tuberculosis (TB) with a high risk of onward transmission can guide disease prevention and public health strategies. Here, we train classification models to predict the first sampled...
3.
Lo C, Purych D, Sekirov I, Khattra J, Hird T, Masud S
J Med Microbiol
. 2024 Oct;
73(10).
PMID: 39436387
We evaluated the Xpert MTB/Rif Ultra assay performance for (MTB) detection in formalin-fixed paraffin-embedded tissue (FFPET) compared to mycobacterial culture or laboratory-developed MTB PCR test (LDT). FFPET samples with histological...
4.
Li F, Faber A, Caleta J, Goldfarb D, Sekirov I, Prystajecky N, et al.
J Infect Dis
. 2024 Aug;
231(2):490-494.
PMID: 39215587
Guillain-Barré syndrome (GBS) is an acute peripheral neuropathy often preceded by respiratory or gastrointestinal infections, though molecular testing of cerebrospinal fluid is often inconclusive. In a recent case of severe...
5.
Kadambari S, Harvala H, Nguyen D, Sadarangani M, Martin N, Al-Rawahi G, et al.
J Clin Virol
. 2024 Jul;
174:105715.
PMID: 39074411
Objectives: We evaluated the extent of virus heterogeneity in PeV infected infants in the UK, Canada and Australia. Methods: Samples were collected from PeV infected infants during 2013-16. Next generation...
6.
Sharma M, Stobart M, Akochy P, Adam H, Janella D, Rabb M, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892433
Phenotypic susceptibility testing of the complex (MTBC) isolate requires culture growth, which can delay rapid detection of resistant cases. Whole genome sequencing (WGS) and data analysis pipelines can assist in...
7.
Gaultier G, McMillan B, Poloni C, Lo M, Cai B, Zheng J, et al.
Sci Rep
. 2024 Apr;
14(1):8926.
PMID: 38637558
To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older, spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin-converting enzyme 2 (ACE2) inhibition surrogate neutralization...
8.
Connors W, Nishi C, Sekirov I, Cook V, Johnston J
Can Commun Dis Rep
. 2024 Mar;
49(1):15-20.
PMID: 38550769
Drug-resistant tuberculosis (TB) is a major global health challenge in part because there are fewer effective treatments and these treatments have been prolonged and more toxic. The evidence base for...
9.
Nikiforuk A, Kuchinski K, Short K, Roman S, Irvine M, Prystajecky N, et al.
BMC Infect Dis
. 2024 Feb;
24(1):262.
PMID: 38408924
Background: Widespread human-to-human transmission of the severe acute respiratory syndrome coronavirus two (SARS-CoV-2) stems from a strong affinity for the cellular receptor angiotensin converting enzyme two (ACE2). We investigate the...
10.
Silverberg S, Shulha H, McMillan B, He G, Lee A, Marquez A, et al.
BMC Infect Dis
. 2024 Jan;
24(1):91.
PMID: 38225625
Background And Objectives: Pediatric COVID-19 cases are often mild or asymptomatic, which has complicated estimations of disease burden using existing testing practices. We aimed to determine the age-specific population seropositivity...